Trials / Recruiting
RecruitingNCT06717490
Magnesium Sulfate and Postoperative Hypercoagulability in Laparoscopic Gynecological Surgeries
Effect of Magnesium Sulfate on Postoperative Hypercoagulability Using Thromboelastometry in Laparoscopic Gynecological Surgeries
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- Marianna Mavromati · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
This will be a prospective randomized, double-blind study, aiming at investigating the effects of magnesium sulfate on postoperative hypercoagulability in patients undergoing laparoscopic gynecological surgeries under general anesthesia
Detailed description
This randomized, double-blind, controlled study investigates the effects of magnesium sulfate on postoperative hypercoagulability in patients undergoing laparoscopic gynecological surgeries under general anesthesia. Using thromboelastometry, the study aims to assess the impact of magnesium sulfate on blood coagulation parameters. Patients are divided into two groups, with one group receiving magnesium sulfate and the other receiving normal saline. Both patients and investigators are blinded to the treatment allocation. The study will analyze clotting time, clot formation, and coagulation markers to evaluate the therapeutic potential of magnesium sulfate in reducing postoperative hypercoagulability.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Magnesium sulphate | In patients allocated to the MS group, a fixed dose of magnesium sulfate diluted in a fixed volume of natural saline will be administered intravenously. Thromboelastometry will be performed pre and post magnesium administration. |
| OTHER | Placebo Drug | In patients allocated to the NS group, a fixed dose of natural saline will be administered intravenously, through a fixed volume of solution. Thromboelastometry will be performed pre and post magnesium administration. |
Timeline
- Start date
- 2024-12-01
- Primary completion
- 2025-11-01
- Completion
- 2025-11-01
- First posted
- 2024-12-05
- Last updated
- 2024-12-05
Locations
1 site across 1 country: Greece
Source: ClinicalTrials.gov record NCT06717490. Inclusion in this directory is not an endorsement.